Rapid quantitative (1)H–(13)C two-dimensional NMR with high precision

por Wu, Yu-Shan, Li, Bai-Xiang, Long, Ying-Yun
Publicado 2022

Talent cultivation in health technology assessment: an expert survey

por Wu, Yu-Shan, Chen, Chiehfeng, Wang, Lin-Chien, Jian, Li-Shan, Ko, Yu
Publicado 2022

AC-93253 iodide, a novel Src inhibitor, suppresses NSCLC progression by modulating multiple Src-related signaling pathways

por Lai, Yi-Hua, Lin, Sih-Yin, Wu, Yu-Shan, Chen, Huei-Wen, Chen, Jeremy J. W.
Publicado 2017

The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs

por Wu, Chung-Pu, Li, Yan-Qing, Chi, Ya-Chen, Huang, Yang-Hui, Hung, Tai-Ho, Wu, Yu-Shan
Publicado 2021

Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport

por Wu, Chung-Pu, Murakami, Megumi, Li, Yen-Ching, Huang, Yang-Hui, Chang, Yu-Tzu, Hung, Tai-Ho, Wu, Yu-Shan, Ambudkar, Suresh V.
Publicado 2023

Incorporation of surface-modified hydroxyapatite into poly(methyl methacrylate) to improve biological activity and bone ingrowth

por Ku, Kuan-Lin, Wu, Yu-Shan, Wang, Chi-Yun, Hong, Ding-Wei, Chen, Zong-Xing, Huang, Ching-An, Chu, I-Ming, Lai, Po-Liang
Publicado 2019

Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents

por Wu, Chung-Pu, Murakami, Megumi, Wu, Yu-Shan, Chi, Ya-Chen, Hsiao, Sung-Han, Huang, Yang-Hui, Hung, Tai-Ho, Ambudkar, Suresh V.
Publicado 2021

Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells

por Li, Yan-Qing, Murakami, Megumi, Huang, Yang-Hui, Hung, Tai-Ho, Wang, Shun-Ping, Wu, Yu-Shan, Ambudkar, Suresh V., Wu, Chung-Pu
Publicado 2022

Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs

por Wu, Chung-Pu, Hsiao, Sung-Han, Huang, Yang-Hui, Hung, Lang-Cheng, Yu, Yi-Jou, Chang, Yu-Tzu, Hung, Tai-Ho, Wu, Yu-Shan
Publicado 2020

Antihelminthic niclosamide modulates dendritic cells activation and function

por Wu, Chieh-Shan, Li, Yi-Rong, Chen, Jeremy J.W., Chen, Ying-Che, Chu, Chiang-Liang, Pan, I-Hong, Wu, Yu-Shan, Lin, Chi-Chen
Publicado 2014

P-glycoprotein Mediates Resistance to the Anaplastic Lymphoma Kinase Inhiitor Ensartinib in Cancer Cells

por Wu, Chung-Pu, Hung, Cheng-Yu, Murakami, Megumi, Wu, Yu-Shan, Lin, Chun-Ling, Huang, Yang-Hui, Hung, Tai-Ho, Yu, Jau-Song, Ambudkar, Suresh V.
Publicado 2022

Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs

por Wu, Chung-Pu, Hung, Tai-Ho, Hsiao, Sung-Han, Huang, Yang-Hui, Hung, Lang-Cheng, Yu, Yi-Jou, Chang, Yu-Tzu, Wang, Shun-Ping, Wu, Yu-Shan
Publicado 2020

ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines

por Wu, Chung-Pu, Hung, Cheng-Yu, Hsieh, Ya-Ju, Murakami, Megumi, Huang, Yang-Hui, Su, Tsung-Yao, Hung, Tai-Ho, Yu, Jau-Song, Wu, Yu-Shan, Ambudkar, Suresh V.
Publicado 2023

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells

por Wu, Chung-Pu, Li, Yen-Ching, Murakami, Megumi, Hsiao, Sung-Han, Lee, Yun-Chieh, Huang, Yang-Hui, Chang, Yu-Tzu, Hung, Tai-Ho, Wu, Yu-Shan, Ambudkar, Suresh V.
Publicado 2023

Facilitating Anti-Cancer Combinatorial Drug Discovery by Targeting Epistatic Disease Genes

por Quan, Yuan, Liu, Meng-Yuan, Liu, Ye-Mao, Zhu, Li-Da, Wu, Yu-Shan, Luo, Zhi-Hui, Zhang, Xiu-Zhen, Xu, Shi-Zhong, Yang, Qing-Yong, Zhang, Hong-Yu
Publicado 2018